Off-label caplacizumab as add-on therapy in a 9-year-old boy with refractory aTTP

Detalles Bibliográficos
Autores principales: Veltroni, Marinella, Pegoraro, Francesco, Scappini, Barbara, Brugnolo, Francesca, Allegro, Elisa, Ermini, Stefano, Tondo, Annalisa, Fotzi, Ilaria, Bambi, Franco, Favre, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072268/
https://www.ncbi.nlm.nih.gov/pubmed/34932149
http://dx.doi.org/10.1007/s00277-021-04740-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072268/
https://www.ncbi.nlm.nih.gov/pubmed/34932149
http://dx.doi.org/10.1007/s00277-021-04740-4

Ejemplares similares